EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

FCGBP Promotes Glioma Growth by Regulating JAK2 / STAT3 /c‐Myc Pathway

Jin Zheng, Yu Xin Rao, Hui Zheng, Liang Liang Shi iD

Cancer Medicine · 2026

DOI: 10.1002/cam4.71617 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Medicine, 2026. Verfasst von Jin Zheng und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China. Hauptthemen laut MEDLINE: Janus Kinase 2, STAT3 Transcription Factor, Glioma, Proto-Oncogene Proteins c-myc. Die Arbeit nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: The Natural Science Foundation of Hubei.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

FCGBP has been implicated in the development of a variety of tumors, but its exact role in glioma progression remains unclear.

Methods

This study utilized qRT‐PCR, Western blotting (WB), immunohistochemistry (IHC), and other techniques to assess FCGBP expression in glioma tissues. Additionally, various functional experiments were conducted to investigate its role in glioma progression. Animal models were employed to further elucidate the function of FCGBP, with a particular focus on its impact on the Janus Kinase 2/Signal Transducer and Activator of Transcription 3 (JAK2/STAT3) signaling pathway.

Results

The research findings indicated that FCGBP is significantly overexpressed in glioma and is closely associated with higher tumor grades and unfavorable clinical outcomes. Functional assays demonstrated that FCGBP promotes glioma cell aggressiveness by activating the JAK2/STAT3 signaling pathway.

Conclusion

This study highlights the critical role of FCGBP in glioma aggression and poor prognosis, indicating that it could serve as a potential therapeutic target.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Janus Kinase 2STAT3 Transcription FactorGliomaProto-Oncogene Proteins c-mycBrain NeoplasmsAnimalsHumansSignal TransductionCell ProliferationMiceCell Line, TumorGene Expression Regulation, NeoplasticMaleFemalePrognosis

Stichwörter der Autor:innen

FCGBPJAK2/STAT3/c‐Mycgliomaprogression

Substanzen

Janus Kinase 2STAT3 Transcription FactorJAK2 protein, humanProto-Oncogene Proteins c-mycSTAT3 protein, humanMYC protein, human

Autor:innen und Institutionen

  • Department of Neurosurgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China.
  • Department of Radiology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China.
  • Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China.

ORCID-Profile: Liang Liang Shi

Förderung

  • The Natural Science Foundation of Hubei

Zitieren

APA

Zheng, J., Rao, Y. X., Zheng, H., & Shi, L. L. (2026). FCGBP Promotes Glioma Growth by Regulating JAK2 / STAT3 /c‐Myc Pathway. Cancer Medicine. https://doi.org/10.1002/cam4.71617

Vancouver

Zheng J, Rao YX, Zheng H, Shi LL. FCGBP Promotes Glioma Growth by Regulating JAK2 / STAT3 /c‐Myc Pathway. Cancer Medicine. 2026. doi:10.1002/cam4.71617

BibTeX
@article{Zheng2026,
  author = {Zheng, Jin and Rao, Yu Xin and Zheng, Hui and Shi, Liang Liang},
  title = {FCGBP Promotes Glioma Growth by Regulating JAK2 / STAT3 /c‐Myc Pathway},
  journal = {Cancer Medicine},
  year = {2026},
  doi = {10.1002/cam4.71617}
}
Kostenlos starten →